SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010617
Filing Date
2021-08-05
Accepted
2021-08-05 17:18:51
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20210630x10q.htm   iXBRL 10-Q 2301160
2 EX-10.1 iova-20210630xex10d1.htm EX-10.1 580416
3 EX-10.2 iova-20210630xex10d2.htm EX-10.2 70674
4 EX-10.3 iova-20210630xex10d3.htm EX-10.3 73806
5 EX-31.1 iova-20210630xex31d1.htm EX-31.1 12336
6 EX-31.2 iova-20210630xex31d2.htm EX-31.2 12224
7 EX-32.1 iova-20210630xex32d1.htm EX-32.1 7088
8 EX-32.2 iova-20210630xex32d2.htm EX-32.2 7171
9 GRAPHIC iova-20210630x10q001.jpg GRAPHIC 51231
  Complete submission text file 0001558370-21-010617.txt   9602601

Data Files

Seq Description Document Type Size
10 EX-101.SCH iova-20210630.xsd EX-101.SCH 50721
11 EX-101.CAL iova-20210630_cal.xml EX-101.CAL 52929
12 EX-101.DEF iova-20210630_def.xml EX-101.DEF 203600
13 EX-101.LAB iova-20210630_lab.xml EX-101.LAB 402069
14 EX-101.PRE iova-20210630_pre.xml EX-101.PRE 361176
15 EXTRACTED XBRL INSTANCE DOCUMENT iova-20210630x10q_htm.xml XML 1693047
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 211149538
SIC: 2836 Biological Products, (No Diagnostic Substances)